Literature DB >> 32020598

Lung cancer incidence in young women vs. young men: A systematic analysis in 40 countries.

Miranda M Fidler-Benaoudia1,2, Lindsey A Torre3, Freddie Bray4, Jacques Ferlay4, Ahmedin Jemal3.   

Abstract

Previous studies have reported converging lung cancer rates between sexes. We examine lung cancer incidence rates in young women vs. young men in 40 countries across five continents. Lung and bronchial cancer cases by 5-year age group (ages 30-64) and 5-year calendar period (1993-2012) were extracted from Cancer Incidence in Five Continents. Female-to-male incidence rate ratios (IRRs) and 95% confidence intervals (95%CIs) were calculated by age group and birth cohort. Among men, age-specific lung cancer incidence rates generally decreased in all countries, while in women the rates varied across countries with the trends in most countries stable or declining, albeit at a slower pace compared to those in men. As a result, the female-to-male IRRs increased among recent birth cohorts, with IRRs significantly greater than unity in Canada, Denmark, Germany, New Zealand, the Netherlands and the United States. For example, the IRRs in ages 45-49 year in the Netherlands increased from 0.7 (95% CI: 0.6-0.8) to 1.5 (95% CI: 1.4-1.7) in those born circa 1948 and 1963, respectively. Similar patterns, though nonsignificant, were found in 23 additional countries. These crossovers were largely driven by increasing adenocarcinoma incidence rates in women. For those countries with historical smoking data, smoking prevalence in women approached, but rarely exceeded, those of men. In conclusion, the emerging higher lung cancer incidence rates in young women compared to young men is widespread and not fully explained by sex differences in smoking patterns. Future studies are needed to identify reasons for the elevated incidence of lung cancer among young women.
© 2020 UICC.

Entities:  

Keywords:  CI5; Cancer Incidence in Five Continents; global; incidence; international; lung cancer

Year:  2020        PMID: 32020598     DOI: 10.1002/ijc.32809

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  23 in total

1.  Gender disparities in incidence and projections of lung cancer in China and the United States from 1978 to 2032: an age-period-cohort analysis.

Authors:  Min Jiang; Cairong Zhu; Minghan Xu; Mandi Li; Jiao Pei; Chenyao Wu; Lin Jiang
Journal:  Cancer Causes Control       Date:  2022-08-02       Impact factor: 2.532

Review 2.  Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality.

Authors:  Asha Bonney; Reem Malouf; Corynne Marchal; David Manners; Kwun M Fong; Henry M Marshall; Louis B Irving; Renée Manser
Journal:  Cochrane Database Syst Rev       Date:  2022-08-03

Review 3.  Role of sex hormones in lung cancer.

Authors:  Nathalie Fuentes; Miguel Silva Rodriguez; Patricia Silveyra
Journal:  Exp Biol Med (Maywood)       Date:  2021-06-03

4.  Therapeutic Potential of Olaparib in Combination With Pembrolizumab in a Young Patient With a Maternally Inherited BRCA2 Germline Variant: A Research Report.

Authors:  Thomas Waddington; Isa Mambetsariev; Rebecca Pharaon; Jeremy Fricke; Angel Ray Baroz; Hannah Romo; Bassam Ghanem; Stacy Gray; Ravi Salgia
Journal:  Clin Lung Cancer       Date:  2021-01-27       Impact factor: 4.840

Review 5.  The emerging role of estrogen related receptorα in complications of non-small cell lung cancers.

Authors:  Tapan K Mukherjee; Parth Malik; John R Hoidal
Journal:  Oncol Lett       Date:  2021-02-04       Impact factor: 2.967

6.  Potential role of glucosamine-phosphate N-acetyltransferase 1 in the development of lung adenocarcinoma.

Authors:  Shengqiang Zhang; Hongyan Zhang; Huawei Li; Jida Guo; Jun Wang; Linyou Zhang
Journal:  Aging (Albany NY)       Date:  2021-03-03       Impact factor: 5.682

Review 7.  An Overview of Lung Cancer in Women and the Impact of Estrogen in Lung Carcinogenesis and Lung Cancer Treatment.

Authors:  Vianey Rodriguez-Lara; Maria Rosa Avila-Costa
Journal:  Front Med (Lausanne)       Date:  2021-05-17

8.  Tumor infiltrating T cells influence prognosis in stage I-III non-small cell lung cancer.

Authors:  Arik Bernard Schulze; Georg Evers; Dennis Görlich; Michael Mohr; Alessandro Marra; Ludger Hillejan; Jan Rehkämper; Lars Henning Schmidt; Birthe Heitkötter
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

9.  Understanding sex disparities in lung cancer incidence: are women more at risk?

Authors:  Meera V Ragavan; Manali I Patel
Journal:  Lung Cancer Manag       Date:  2020-06-22

Review 10.  Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancer.

Authors:  Nuria Mederos; Alex Friedlaender; Solange Peters; Alfredo Addeo
Journal:  ESMO Open       Date:  2020-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.